The Pfizer, Baxter and Celgene-backed oncology company will raise $43.7m from an initial public offering where the share price was effectively halved in the space of two weeks.

Mars Investment and Takeda back Toronto spinout Encycle in C$2.85m round.

The Pfizer, Baxter and Celgene-backed oncology company will raise $43.7m from an initial public offering where the share price was effectively halved in the space of two weeks.

Immuno-oncology company Neon Therapeutics has been launched with $55m of series A capital supplied by investors including Access Industries.

The insurance group backed a $2m extension to BeneStream's series A round, which has closed at almost $6.3m.

MemorialCare Health system contributed to a round that took healthcare communication platform PerfectServe's funding to about $35m since 2002.

Cambridge spinouts Aqdot and Cytora receive investment from UK-based investor Parkwalk and the university.

MemorialCare Health system contributed to a round that took healthcare communication platform PerfectServe's funding to about $35m since 2002.

AbbVie and WuXi PharmaTech joined limited partners already including Eli Lilly, Pfizer and Johnson & Johnson to help the early-stage venture firm close its fourth fund.